Revvity Inc (RVTY)
103.03
+0.21
(+0.20%)
USD |
NYSE |
May 07, 13:56
Revvity SG&A Expense (Quarterly): 260.57M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 260.57M |
December 31, 2023 | 251.75M |
September 30, 2023 | 250.75M |
June 30, 2023 | 269.31M |
March 31, 2023 | 248.56M |
December 31, 2022 | 244.32M |
September 30, 2022 | 242.74M |
June 30, 2022 | 260.62M |
March 31, 2022 | 275.26M |
December 31, 2021 | 293.88M |
September 30, 2021 | 275.87M |
June 30, 2021 | 281.82M |
March 31, 2021 | 251.41M |
December 31, 2020 | 61.62M |
September 30, 2020 | 225.25M |
June 30, 2020 | 221.03M |
March 31, 2020 | 208.57M |
December 31, 2019 | 210.74M |
September 30, 2019 | 204.17M |
June 30, 2019 | 201.55M |
March 31, 2019 | 198.86M |
December 31, 2018 | 210.54M |
September 30, 2018 | 196.77M |
June 30, 2018 | 204.88M |
March 31, 2018 | 199.72M |
Date | Value |
---|---|
December 31, 2017 | 176.38M |
September 30, 2017 | 152.78M |
June 30, 2017 | 149.86M |
March 31, 2017 | 147.01M |
December 31, 2016 | 152.38M |
September 30, 2016 | 142.60M |
June 30, 2016 | 150.95M |
March 31, 2016 | 144.54M |
December 31, 2015 | 146.88M |
September 30, 2015 | 147.73M |
June 30, 2015 | 146.74M |
March 31, 2015 | 145.87M |
December 31, 2014 | 205.52M |
September 30, 2014 | 143.00M |
June 30, 2014 | 147.25M |
March 31, 2014 | 152.44M |
December 31, 2013 | 140.88M |
September 30, 2013 | 142.78M |
June 30, 2013 | 147.80M |
March 31, 2013 | 151.50M |
December 31, 2012 | 175.34M |
September 30, 2012 | 145.44M |
June 30, 2012 | 149.74M |
March 31, 2012 | 156.85M |
December 31, 2011 | 220.18M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
61.62M
Minimum
Dec 2020
293.88M
Maximum
Dec 2021
236.99M
Average
249.65M
Median
SG&A Expense (Quarterly) Benchmarks
Agilent Technologies Inc | 396.00M |
Bruker Corp | 195.40M |
Azenta Inc | 78.58M |
Harvard Bioscience Inc | 11.51M |
Bionano Genomics Inc | 15.69M |